Oral treatment of seborrhea with cysteamine derivatives

Details Oral treatment of seborrhea with cysteamine derivatives Oral treatment of seborrhea with cysteamine derivatives

1976-01-29

1977-07-12

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

26029385, 424320, 2602948F, 2602948G, 424321, 2602948R, 26032684, 424322, 260470, 424324, 260479S, 260481R, 424325, 26050119, 26050121, 424330, 260515M, 260518A, 260518R, 260534S, 260553E, 260558H, 2605705S, 260558S, 424DIG4, 42424851, 424250, 424263, 424266, 424274, 424275, 424282, 424285, 424300, 424311, 424316, 424319, 42424852, A61K 3119, A61K 31205

Patent

active

040354920

ABSTRACT:
A method for treating a scalp characterized by an excessive secretion of sebum, to improve the condition thereof by reducing said excessive secretion comprising orally administering to a human being having a scalp so characterized a therapeutic composition comprising an ingestible carrier admixed with, as a non-toxic active compound, cysteine or cysteamine derivatives, the active compound is present in amounts of about 0.75-3 weight percent of the composition which is administered at a rate of about 1-5 mg/kg/day based on the weight of the human being during a period of about 15 days.

REFERENCES:
patent: 2769839 (1956-11-01), Fincke
patent: 2835704 (1958-05-01), Walton

Affiliated with

Also associated with

Rating

Oral treatment of seborrhea with cysteamine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral treatment of seborrhea with cysteamine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral treatment of seborrhea with cysteamine derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-488400